---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-082250"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2026-07-09T20:01:22+00:00"
generated_at: "2026-07-09T20:02:07.495741+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma shareholders approve 2M share increase in incentive plan and warrant issuance at annual meeting

## Summary
- Stockholders approved amendment to 2021 Incentive Compensation Plan, increasing authorized shares by 2,000,000 (4,821,796 for, 1,694,075 against).
- Proposal 4 approved issuance of shares upon exercise of Series B and C Warrants issued under April 15, 2026 Securities Purchase Agreement (2,270,414 for, 151,196 against).
- All seven director nominees elected; KPMG ratified as auditor for FY 2026 (7,659,805 for).
- Certain shares (3,486,423) excluded from voting on Proposal 4 per Nasdaq rules; total outstanding shares 15,150,669 as of May 18, 2026 record date.

## SEC filing metadata
- accession: 0001104659-26-082250
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2026-07-09T20:01:22+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465926082250/0001104659-26-082250-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465926082250/tm2620113d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-082250
- JSON: https://secwatch.observer/filing/0001104659-26-082250.json
- Plain text: https://secwatch.observer/filing/0001104659-26-082250.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.